A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Active, not recruiting · NCT01770418 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT01770418 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Proton Collaborative Group | 9 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hampton University Proton Therapy Institute | Hampton | United States | 7 |
| Maryland Proton Treatment Center | Baltimore | United States | 32 |
| Northwestern Medicine Chicago Proton Center | Warrenville | United States | 9 |
| Oklahoma Proton Center | Oklahoma City | United States | 7 |
| Princeton ProCure Management LLC | Somerset | United States | 1 |
| University of Florida Proton Therapy Institute | Jacksonville | United States | 6 |